Perspectives on Newer Antiobesity Drugs (Semaglutide and Tirzepatide) among Healthcare Professionals Treating Obesity in South Asia: A Cross-sectional Survey.
- DOI
- 10.59556/japi.74.1709
- Published
- 2026 Sep 1
- Container
- The Journal of the Association of Physicians of India
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.59556/japi.74.1709,
title = {Perspectives on Newer Antiobesity Drugs (Semaglutide and Tirzepatide) among Healthcare Professionals Treating Obesity in South Asia: A Cross-sectional Survey.},
author = {Agarwal K and Nagendra L and Bhattacharya S and Sharma S and Kamrul-Hasan A and Kapoor N and Shreshtha D and Das S and Sheikh S and Mehta R and Pankaj A and Riaz M and Kalra S},
year = {2026},
journal = {The Journal of the Association of Physicians of India},
doi = {10.59556/japi.74.1709},
url = {https://doi.org/10.59556/japi.74.1709}
}RIS
TY - JOUR TI - Perspectives on Newer Antiobesity Drugs (Semaglutide and Tirzepatide) among Healthcare Professionals Treating Obesity in South Asia: A Cross-sectional Survey. AU - Agarwal K AU - Nagendra L AU - Bhattacharya S AU - Sharma S AU - Kamrul-Hasan A AU - Kapoor N AU - Shreshtha D AU - Das S AU - Sheikh S AU - Mehta R AU - Pankaj A AU - Riaz M AU - Kalra S PY - 2026 JO - The Journal of the Association of Physicians of India DO - 10.59556/japi.74.1709 UR - https://doi.org/10.59556/japi.74.1709 ER -
APA
K, A., L, N., S, B., S, S., A, K., N, K., D, S., S, D., S, S., R, M., A, P., M, R., & S, K. (2026). Perspectives on Newer Antiobesity Drugs (Semaglutide and Tirzepatide) among Healthcare Professionals Treating Obesity in South Asia: A Cross-sectional Survey.. The Journal of the Association of Physicians of India. https://doi.org/10.59556/japi.74.1709
Source records
- pubmed · retrieved 2026-11-10T04:53:58.786Z